Related references
Note: Only part of the references are listed.Cancer as a metabolic disease: implications for novel therapeutics
Thomas N. Seyfried et al.
CARCINOGENESIS (2014)
The impact of preoperative immunonutrition and other nutrition models on tumor infiltrative lymphocytes in colorectal cancer patients
Kasim Caglayan et al.
AMERICAN JOURNAL OF SURGERY (2012)
Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery
J. Sultan et al.
BRITISH JOURNAL OF SURGERY (2012)
Plasma Fatty Acid Composition in Patients with Pancreatic Cancer: Correlations to Clinical Parameters
Jaroslav Macasek et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer
Takanori Maruyama et al.
NUTRITION (2011)
Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies
Y. Bao et al.
BRITISH JOURNAL OF CANCER (2010)
Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients
R. A. Murphy et al.
CLINICAL NUTRITION (2010)
Cancer as a metabolic disease
Thomas N. Seyfried et al.
NUTRITION & METABOLISM (2010)
Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer
Giovanni Mantovani et al.
ONCOLOGIST (2010)
Multi-targeted therapy of cancer by omega-3 fatty acids
Isabelle M. Berquin et al.
CANCER LETTERS (2008)
Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential cox-2 inhibition on systemic syndromes in patients with advanced lung cancer
Leandro C. A. Cerchietti et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2007)
Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia
Kenneth C. H. Fearon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer
J Bauer et al.
CLINICAL NUTRITION (2005)
Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients
MD Barber et al.
CLINICAL SCIENCE (2004)
Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer
W Davidson et al.
CLINICAL NUTRITION (2004)
Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids
AWG Moses et al.
BRITISH JOURNAL OF CANCER (2004)
Effects of omega-3 fatty acid supplementation on tumor-bearing rats
EJB Ramos et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
KCH Fearon et al.
GUT (2003)
Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: A double-blind, placebo-controlled study
E Bruera et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Supportive use of megestrol acetate (megace) with head/neck and lung cancer patients receiving radiation therapy
RP McQuellon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia
MD Barber et al.
LIPIDS (2001)
Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia
MD Barber et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)
Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation
SD Zuijdgeest-Van Leeuwen et al.
CLINICAL NUTRITION (2000)
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement
MD Barber et al.
CLINICAL SCIENCE (2000)
Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer
SJ Wigmore et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2000)
Share Paper
